A New Luminescent Beacon for Rapid Drug and Toxin Screening
A significant advancement in biosensor technology, published in Communications Biology, introduces CalLuc-2.1, a novel luminescent calcium biosensor designed for endpoint measurement of Gq/11-coupled GPCR signaling. This tool addresses a critical bottleneck in emergency and acute care pharmacology by converting transient calcium spikes into stable, easily measurable luminescent signals. The innovation enables simple, high-throughput endpoint assays, which are crucial for rapid drug screening and, notably, for the direct detection of endogenous ligands and potential toxins in complex biological samples like human serum. This development represents a leap forward in point-of-care diagnostic potential for conditions mediated by GPCR pathways.
Study Significance: For emergency medicine and toxicology, this biosensor technology could revolutionize the landscape of rapid diagnostic testing and overdose management. It offers a pathway to faster, more reliable point-of-care identification of specific intoxicants or endogenous crisis markers, directly informing targeted antidote administration and acute care protocols. Integrating such a tool into emergency department workflows could significantly reduce diagnostic uncertainty in cases of altered mental status or suspected poisoning, enabling more precise and timely interventions.
Source →Stay curious. Stay informed — with Science Briefing.
This is a one time Briefing, Upgrade to continue.
